Cancer Research
-
Why Microsatellite Instability Status Dictates Rectal Cancer Treatment Choices
MSI-H status identifies rectal cancer patients who may avoid surgery via dostarlimab, a new FDA-approved immunotherapy targeting defective DNA repair.
-
Why KRAS Was Considered Undruggable for Decades and What Finally Cracked It
A smooth protein surface and high GTP affinity stymied drugmakers until a cysteine at G12C enabled covalent inhibitors like divarasib.
-
Fulvic Acid and Cancer: What the 14-Hour Melanoma Study Actually Found
A viral reel cites a 2022 lab study on melanoma cells. Here is what it tested, what it found and what it…
-
What Clinical Trials Really Show About Tigilanol Tiglate from the Blushwood Berry
A viral social media post revived interest in the rainforest drug, but current human trials reveal targeted local results rather than a…
-
MK615 Apricot Extract: Lab Promise vs. Limited Human Trial Data
While viral clips claim MK615 kills 95% of cancer cells, a small Phase I trial showed only disease stabilization, not tumor shrinkage,…
-
Amgen and AstraZeneca Combination Therapy Shows Unprecedented Survival Gains in Lung Cancer
New Phase 3 data reveals that combining Imdelltra with Imfinzi slashes death risk by 58% in patients with extensive-stage small cell lung…
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
A phase 1 trial of an engineered CD40 antibody published in Cancer Cell found tumor shrinkage in half of 12 patients, with…
-
How Personalized mRNA Vaccines Target Neoantigens to Beat Melanoma
Discover how custom mRNA cancer vaccines train the immune system against tumor neoantigens to prevent melanoma recurrence compared to standard adjuvant therapy.
-
How Liquid Biopsy Is Transforming Cancer Monitoring and Early Detection Strategies
Non-invasive blood tests are moving beyond niche use to become vital tools for tracking treatment response, detecting recurrence, and screening for cancer.
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
The 2026 AACR Cancer Progress Report highlights a rise in survival rates and the emergence of innovative drug classes like PROTACs and…
-
European Regulators Back Breakthrough Pancreatic Cancer Drug Rasonque
The EMA has recommended approval for daraxonrasib, a daily pill that doubles survival rates for patients with metastatic pancreatic adenocarcinoma.
-
How a Hidden Fat-Sensing Protein Could Unlock Immunotherapy for Deadly Colorectal Cancers
A new study reveals how tweaking a single molecular switch in immune cells could turn ‘untreatable’ tumors into immunotherapy responders—without headlines.
-
How Texas’ $6B CPRIT Outpaces NIH in Speeding Cancer Breakthroughs
The state’s aggressive funding model recruits top researchers and accelerates treatments—while federal grants face slower bureaucratic hurdles.
-
FDA Expands Approval of Nogapendekin Alfa with BCG for High-Grade Papillary-Only BCG-Unresponsive NMIBC
Silver Spring, October 16 — On October 14, 2026, the U.S. Food and Drug Administration approved an expanded use of nogapendekin alfa…
-
Cancer Researchers Face Funding Gaps and Scientific Hurdles as Personal Stories Drive Public Support
Despite rising prevention knowledge and fundraising success, scientists cite funding instability and complex tumor biology as key barriers to progress in cancer…
-
How a Lung Cancer Discovery Led to a Major Cancer Breakthrough
Los Angeles, October 7 Patients with KRAS-mutant advanced pancreatic cancer now have a treatment that nearly doubles survival time, according to recent…
-
Publication of ROADS Phase 3 Trial Data Recommends GammaTile® as New Standard-of-Care for Brain Metastases
HOUSTON, October 2 — GT Medical Technologies announced on September 29, 2026, that the results of the randomized, multicenter ROADS trial (NCT04365374)…
-
New Blood Test Detects Pancreatic Cancer at Precancerous Stage
BALTIMORE, September 17 — A new liquid biopsy blood test can detect pancreatic cancer at its earliest stages, including when it is…
-
RFK Jr.’s Controversial Beliefs: Barrier to Cancer Cure?
NEW YORK, August 26 — It’s a geopolitical predicament wrapped in a medical enigma: as science edges closer to vaccines against certain…
-
Merck, Moderna Progress mRNA Cancer Vaccine Trial in Late-Stage Melanoma
New York, August 20 — Merck and Moderna announced successful results from a late-stage clinical trial for an mRNA-based cancer vaccine targeting…
-
Scientific review identifies dCK enzyme as potential cancer therapy target
LOS ANGELES, July 17 — A new comprehensive review is pointing cancer researchers toward an old metabolic enzyme, one that could offer…
-
Oncotype DX Test Alters Chemotherapy Decisions in Early Breast Cancer
NEW YORK, July 17 — For patients facing a breast cancer diagnosis, the decision about chemotherapy has long been one of medicine’s…
-
Clinical Validation of Oncotype DX: Key Trials and Results
WASHINGTON, July 17 — The strategic calculus of breast cancer treatment has shifted decisively over the past two decades, driven by a…
-
Harvard Retracts Cancer Paper Over Image Duplication
BOSTON, July 17 — On the ground at Brigham and Women’s Hospital, a team of researchers has lost a published paper after…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Legal Battles Over Cancer Funding Delay Life-Saving Care for Patients
-
Stanford Digital Twins Identify Drug Combo To Stop Premature Birth
-
Why Microsatellite Instability Status Dictates Rectal Cancer Treatment Choices
-
Why KRAS Was Considered Undruggable for Decades and What Finally Cracked It
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
How Private Credit Facilities Expand Access to Affordable Consumer Lending
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds